Hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitors as first-line treatment for hepatocellular carcinoma with high tumor burden and portal vein tumor thrombus: A target trial emulation study (CHANCE 2416).
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: First Hospital of China Medical University, China Medical University, Yanbian University, Yanbian University Hospital, First Affiliated Hospital of Dalian Medical University, Third Affiliated Hospital of Harbin Medical University, Xiangya Hospital Central South University, Sun Yat-sen University Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, West China Hospital of Sichuan University, First Hospital of Jilin University, Liaoning Cancer Hospital & Institute, Jilin University, Jinzhou Medical University, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, University of Science and Technology of China, Peking University Cancer Hospital, Zhongda Hospital Southeast University, Southeast University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162542570
Cites:
Cited by:
Related to: